Daniel Castro

Skip to main content

FDA Approves PTC’s Gene Therapy for AADC Deficiency

Main Menu

Search:

About PTC
Our Science
Our Products & Pipeline
Therapeutic Areas
Careers

Start of Column
- Americas
  - United States
- Asia
  - Japan
Start of Column
- Europe
  - Austria
  - Germany
  - Ireland
  - Italy
  - Spain
  - Sweden (EN)
  - Sweden
  - Switzerland
  - United Kingdom

Investors
Healthcare Providers
Patients & Caregivers

Search:

Start of Column
- Americas
  - United States
- Asia
  - Japan
Start of Column
- Europe
  - Austria
  - Germany
  - Ireland
  - Italy
  - Spain
  - Sweden (EN)
  - Sweden
  - Switzerland
  - United Kingdom

Investors
Healthcare Providers
Patients & Caregivers

Get to know PTC

History
Leadership Team
Our Responsibility
Grants and Donations
PTC Newsroom
Global Compliance

For Patients

PTC Cares
Insightful Moments
Rare Journeys
Patient & Caregiver Resources

Clinical Trials
Careers
Our Pipeline
Approved Medicines
Investor Relations

Have Questions?

Contact Us

Follow Us On:

Terms of Use Privacy Statement Cookie Statement California Residents

You are about to leave PTCbio.com

You are now leaving https://www.ptcbio.com, a website provided by PTC Therapeutics Inc. This link will take you to a website to which our Privacy Statement, Cookie Statement and Terms of Use Agreement do not apply. PTC does not endorse and/or influence the content found on websites not owned/operated by PTC.

Continue